Trinity Biotech (TRIB) Amortizatization of Intangibles (2021 - 2024)
Trinity Biotech's (TRIB) quarterly Amortizatization of Intangibles came in at $109000.0 in Q4 2024, down 76.3% year-on-year from $460000.0 in Q1 2024, and up 32148.52% quarter-over-quarter from $338.0 in Q3 2024.
Trinity Biotech (TRIB) Amortizatization of Intangibles (2021 - 2024) Analysis & Trends
Trinity Biotech has disclosed Amortizatization of Intangibles across 4 years of filings, most recently posting $109000.0 for Q4 2024.
- Amortizatization of Intangibles for Q4 2024 came in at $109000.0, down 76.3% year-over-year; the trailing twelve-month figure through Dec 2024 was $110083.0 (down 76.09% YoY), and the FY2025 annual result was $1.4 million, up 16.39% from the prior year.
- Amortizatization of Intangibles came in at $109000.0 for Q4 2024 at Trinity Biotech, up from $338.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $460000.0 in Q4 2023 to a low of $56.0 in Q3 2023.
- The 4-year median for Amortizatization of Intangibles is $338.0 (2024), against an average of $98463.3.
- Across the five-year window, Amortizatization of Intangibles slumped 99.98% in 2023 and soared 503.57% in 2024, its largest moves.
- Trinity Biotech's Amortizatization of Intangibles stood at $228000.0 in 2021, then decreased by 5.7% to $215000.0 in 2022, then soared by 113.95% to $460000.0 in 2023, then plunged by 76.3% to $109000.0 in 2024.
- The last three Amortizatization of Intangibles figures came in at $109000.0 (Q4 2024), $338.0 (Q3 2024), and $218.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 6.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 75.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Trinity Biotech | 26,200.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 109,000.00 |
| Dec 31, 2024 | 109,000.00 |
| Sep 30, 2024 | 338.00 |
| Sep 30, 2024 | 338.00 |
| Jun 30, 2024 | 218.00 |
| Jun 30, 2024 | 218.00 |
| Mar 31, 2024 | 527.00 |
| Mar 31, 2024 | 527.00 |
| Dec 31, 2023 | 460,000.00 |
| Dec 31, 2023 | 460,000.00 |
| Sep 30, 2023 | 56.00 |
| Sep 30, 2023 | 56.00 |
| Jun 30, 2023 | 179.00 |
| Jun 30, 2023 | 179.00 |
| Mar 31, 2023 | 251.00 |
| Mar 31, 2023 | 251.00 |
| Dec 31, 2022 | 215,000.00 |
| Dec 31, 2022 | 215,000.00 |
| Sep 30, 2022 | 266,000.00 |
| Sep 30, 2022 | 266,000.00 |